Accelerate Diagnostics EBITDA 2010-2024 | AXDX
Accelerate Diagnostics ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Accelerate Diagnostics Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-23 |
| 2023 | $-46 |
| 2022 | $-58 |
| 2021 | $-57 |
| 2020 | $-49 |
| 2019 | $-61 |
| 2018 | $-72 |
| 2017 | $-62 |
| 2016 | $-64 |
| 2015 | $-44 |
| 2014 | $-30 |
| 2013 | $-15 |
| 2012 | $0 |
| 2012 | $-5 |
| 2011 | $0 |
| 2010 | $1 |
| 2009 | $0 |
| Accelerate Diagnostics Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-4 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $-6 |
| 2024-03-31 | $-8 |
| 2023-12-31 | $-9 |
| 2023-09-30 | $-12 |
| 2023-06-30 | $-11 |
| 2023-03-31 | $-15 |
| 2022-12-31 | $-13 |
| 2022-09-30 | $-14 |
| 2022-06-30 | $-17 |
| 2022-03-31 | $-15 |
| 2021-12-31 | $-16 |
| 2021-09-30 | $-11 |
| 2021-06-30 | $-14 |
| 2021-03-31 | $-16 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-12 |
| 2020-06-30 | $-12 |
| 2020-03-31 | $-14 |
| 2019-12-31 | $-15 |
| 2019-09-30 | $-15 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-16 |
| 2018-12-31 | $-17 |
| 2018-09-30 | $-17 |
| 2018-06-30 | $-18 |
| 2018-03-31 | $-20 |
| 2017-12-31 | $-16 |
| 2017-09-30 | $-17 |
| 2017-06-30 | $-16 |
| 2017-03-31 | $-14 |
| 2016-12-31 | $-15 |
| 2016-09-30 | $-17 |
| 2016-06-30 | $-17 |
| 2016-03-31 | $-15 |
| 2015-12-31 | $-13 |
| 2015-09-30 | $-11 |
| 2015-06-30 | $-12 |
| 2015-03-31 | $-9 |
| 2014-12-31 | $-8 |
| 2014-09-30 | $-8 |
| 2014-06-30 | $-8 |
| 2014-03-31 | $-6 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-2 |
| 2012-12-31 | |
| 2012-10-31 | $-2 |
| 2012-09-30 | $-2 |
| 2012-07-31 | |
| 2012-06-30 | $-1 |
| 2012-04-30 | $0 |
| 2012-03-31 | $0 |
| 2012-01-31 | $0 |
| 2011-10-31 | $0 |
| 2011-07-31 | |
| 2011-04-30 | $0 |
| 2011-01-31 | $0 |
| 2010-10-31 | $0 |
| 2010-07-31 | |
| 2010-04-30 | $0 |
| 2010-01-31 | $0 |
| 2009-10-31 | $0 |
| 2009-07-31 | |
| 2009-04-30 | $0 |
| 2009-01-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.013B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||